Document is current
Any future updates will be listed below
-
Authors
Valdes, Ana M.
Louca, Panayiotis
Visconti, Alessia
Asnicar, Francesco
Bermingham, Kate
Nogal, Ana
Wong, Kari
Michelotti, Gregory A.
Wolf, Jonathan
Segata, Nicola
Spector, Tim D.
Berry, Sarah E.
Falchi, Mario
Menni, Cristina
- License Information
-
More Information
Article History
Received: 10 April 2024
Accepted: 28 July 2024
First Online: 7 August 2024
Declarations
:
: All participants provided written informed consent. TwinsUK was approved by the St Thomas’ Hospital Research Ethics Committee (REC Ref: EC04/015). Ethical approval for ZOE PREDICT-1 was obtained from St. Thomas Hospital research ethics committees and all individuals provided informed written consent (IRAS 236407) and the trial was registered on ClinicalTrials.gov (registration number: NCT03479866).
: Not applicable.
: TDS is a co-founder and shareholder of ZOE Ltd. AMV, SEB, KB, FA, and NS are consultants to Zoe Ltd (‘Zoe’). JW is an employee of Zoe. KW and GAM are employees of Metabolon Inc. Other authors declare that they have no competing interests.Supplementary information.
